Northwestern Mutual Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $172K | Sell |
|
|||||
2025
Q1 | $3.74M | Buy |
|
|||||
2024
Q4 | $313K | Buy |
|
|||||
2024
Q3 | $283K | Sell |
|
|||||
2024
Q2 | $10.4M | Buy |
|
|||||
2024
Q1 | $12M | Buy |
|
|||||
2023
Q4 | $9.95M | Buy |
|
|||||
2023
Q3 | $7.7M | Buy |
|
|||||
2023
Q2 | $218K | Buy |
|
|||||
2023
Q1 | $207K | Buy |
|
|||||
2022
Q4 | $215K | Sell |
|
|||||
2022
Q3 | $231K | Sell |
|
|||||
2022
Q2 | $253K | Buy |
|
|||||
2022
Q1 | $285K | Buy |
|
|||||
2021
Q4 | $265K | Buy |
|
|||||
2021
Q3 | $250K | Buy |
|
|||||
2021
Q2 | $205K | Sell |
|
|||||
2021
Q1 | $441K | Sell |
|
|||||
2020
Q4 | $880K | Buy |
|
|||||
2020
Q3 | $598K | Buy |
|
|||||
2020
Q2 | $22K | Sell |
|
|||||
2020
Q1 | $21K | Sell |
|
|||||
2019
Q4 | $646K | Buy |
|
|||||
2019
Q3 | $551K | Buy |
|
|||||
2019
Q2 | $575K | Buy |
|
|||||
2019
Q1 | $573K | Buy |
|
|||||
2018
Q4 | $11K | Sell |
|
|||||
2018
Q3 | $26K | Hold |
|
|||||
2018
Q2 | $22K | Hold |
|
|||||
2018
Q1 | $21K | Sell |
|
|||||
2017
Q4 | $26K | Buy |
|
|||||
2017
Q3 | $24K | Buy |
|
|||||
2017
Q2 | $20K | Buy |
|
|||||
2017
Q1 | $12K | Buy |
|
|||||
2016
Q4 | $6K | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $4K | Buy |
|
|||||
2016
Q1 | $2K | Buy |
|
|||||
2015
Q1 | – | Sell |
|
|||||
2014
Q4 | $13K | Hold |
|
|||||
2014
Q3 | $12K | Hold |
|
|||||
2014
Q2 | $11K | Hold |
|
|||||
2014
Q1 | $12K | Hold |
|
|||||
2013
Q4 | $11K | Hold |
|
|||||
2013
Q3 | $9K | Hold |
|
|||||
2013
Q2 | $8K | Buy |
|